|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Phase II Trial: Undifferentiated Versus Differentiated Autologous Mesenchymal Stem Cells Transplantation in Egyptian Patients with HCV Induced Liver Cirrhosis显示文摘 | Mervat El-Ansary Iman Abdel-Aziz Sherif Mogawer Samah Abdel-Hamid Olfat Hammam Salwa Teaema Marwa Wahdan | 2012 | Stem Cell Reviews and Reports2012，，3： | 4 |
| 2 | The Effect of a Flipping Classroom on Writing Skill in English as a Foreign Language and Students' Attitude Towards Flipping显示文摘 | Mervat Abd Elfatah Ali Said Ahmed | 2016 | US-China Foreign Language2016，14，2： | 3 |
| 3 | Immunotherapy by autologous dendritic cell vaccine in patients with advanced HCC显示文摘 | Mervat El Ansary Sherif Mogawer Samah Abd Elhamid Sahr Alwakil Fatma Aboelkasem Hatem El Sabaawy Olfat Abdelhalim | 2013 | Journal of Cancer Research and Clinical Oncology2013，，： | 2 |
| 4 | Electron beam processed plasticized epoxy coatings for surface protection显示文摘 | Mervat S. Ibrahim Heba A. Mohamed Nadia G. Kandile Hossam M. Said Issa M. Mohamed | 2011 | Materials Chemistry and Physics2011，，1： | 2 |
| 5 | Towards hepatitis C virus elimination:Egyptian experience,achievements and limitations显示文摘Worldwide, more than one million people die each year from hepatitis C virus(HCV) related diseases, and over 300 million people are chronically infected with hepatitis B or C. Egypt used to be on the top of the countries with heavy HCV burden. Some countries are making advances in elimination of HCV, yet multiple factors preventing progress; remain for the majority. These factors include lack of global funding sources for treatment, late diagnosis, poor data, and inadequate screening. Treatment of HCV in Egypt has become one of the top national priorities since 2007. Egypt started a national treatment program intending to provide cure for Egyptian HCV-infected patients. Mass HCV treatment program had started using Pegylated interferon and ribavirin between 2007 and 2014. Yet, with the development of highly-effective direct acting antivirals(DAAs) for HCV, elimination of viral hepatitis has become a real possibility. The Egyptian National Committee for the Control of Viral Hepatitis did its best to provide Egyptian HCV patients with DAAs. Egypt adopted a strategy that represents a model of care that could help other countries with high HCV prevalence rate in their battle against HCV. This review covers the effects of HCV management in Egyptian real life settings and the outcome of different treatment protocols. Also, it deals with the current and future strategies for HCV prevention and screening as well as the challenges facing HCV elimination and the prospect of future eradication of HCV. | Dalia Omran Mohamed Alboraie Rania A Zayed Mohamed-Naguib Wifi Mervat Naguib Mohamed Eltabbakh Mohamed Abdellah Ahmed Fouad Sherief Sahar Maklad Heba Hamdy Eldemellawy Omar Khalid Saad Doaa Mohamed Khamiss Mohamed El Kassas | 2018 | World Journal of Gastroenterology2018，24，38： | 2 |
| 6 | P53 rs1042522 and CD95 rs1800682 genetic variations in HCV-4a response to antiviral therapy显示文摘Current estimates indicate that the hepatitis C(HCV)is the leading cause of mortality around the world,with infection rates steadily increasing in Egypt.The dual therapy for this silent epidemic with pegylated-interferon-a2b/ribavirin has markedly improved the success rates in genotype-4 patients.It was reported that apoptosis plays a vital mechanistic role in limiting viral replication.P53,a key regulator of apoptosis,induces CD95 gene expression and subsequently initiates apoptotic cascade to be activated.The current study examined the impact of P53 rs1042522 and CD95 rs1800682 polymorphisms on the treatment response.Three groups of 240 volunteers were enrolled in this study;86 in sustained virological responders group,74 in non-responders group,and 80 in control group.All patients had HCV genotype-4a and were interferon treatment naı¨ve.Quantizations of HCV-RNA by qRT-PCR and histological scores were performed for all patients.In addition,genotyping of HCV-RNA,P53 rs1042522 Arg/Pro and CD95 rs1800682 A/G polymorphisms were investigated in all subjects.It was resulted that P53 Pro/Pro homozygous genotype has high significant increase,while CD95 A/A homozygous genotype has high significant decrease when comparing non-responders with responders.Finally,it was concluded that Pro variant of P53 rs1042522 may be used as a genetic predictor for non-responsiveness,while A/A variant of CD95 rs1800682 may be used as a sensitive biomarker for responsiveness to antiviral therapy of HCV genotype-4a infection.In addition,low prolactin,high total testosterone,and high GH levels may provide promising biomarkers for early prediction of the response when associated with these genetic polymorphisms. | Ahmed A.Abd-Rabou Emad F.Eskander Mervat S.Mohamed Shaymaa M.M.Yahya Ashraf El Sherbini Olfat G.Shaker | 2015 | Genes & Diseases2015，2，2： | 1 |
| 7 | The role of CK7, Ki‐67, CD34 and vimentin in the differentiation between biliary atresia and idiopathic neonatal hepatitis in Egyptian cholestatic neonates显示文摘 | HAYAM ABDEL SAMIE AIAD MONA ABDEL HALIM KANDIL REHAB MONIR SAMAKA MERVAT MAHMOUD SULTAN MOHAMED TAWFIK BADR GAMMAL ELDIN MAHMOUD NADA | 2012 | APMIS2012，，7： | 1 |
| 8 | Survey of anesthesia practice in spine surgery patients in the United States 显示文摘 | Jordan Blinder Mervat EI-Mansouri Neil Roy Connelly | 2003 | J Anesthesia2003，17，1： | 1 |
| 9 | Malondialdehyde and coenzyme Q10 in platelets and serum in type 2 diabetes mellitus: correlation with glycemic control显示文摘 | Eman A El-ghoroury Hala M Raslan Ehsan A Badawy Gamila S El-Saaid Mervat H Agybi Ibrahem Siam Sohair I Salem | 2009 | Blood Coagulation & Fibrinolysis2009，，4： | 1 |
| 10 | New Routes to Steroidal Heterocyclic Derivatives:Synthesis of Biologically Active Pyrazolyl-and Isoxazolylpregnene Derivatives显示文摘 | Abdelhamid A O Mervat M A Gamal A E | 2007 | J Heterocycl Chem2007，44，1： | 1 |
| 11 | Essramycin:A first triazolopyrimidine antibiotic isolated from nature 显示文摘 | MERVAT M A EI-GENDY MOHAMED SHAABAN KHALED A SHAA- BAN | 2008 | Journal of Antibiotic2008，61，： | 1 |
| 12 | Combined radiofrequency and chemoembolization vs.chemoembolization in management of hepatocellular carcinoma显示文摘Aim:Hepatocellular carcinoma(HCC)is one of the most common cancers in the world.If left untreated,liver cancer has a poor prognosis with more than 90%of patients dying of the disease within 5 years of diagnosis.The aim of this study is to assess the value of combined radiofrequency ablation(RFA),followed by trans-arterial chemoembolization(TACE)in the management of HCC.Methods:Fifty HCC patients with chronic liver disease were categorized into two groups according to the modality of locoregional treatment:25 HCC patients treated with RFA followed by TACE within 5 days and 25 HCC patients treated with TACE only.Results:Complete response was achieved in 100%and 84%of the HCC patients after 1 month from combined RFA-TACE therapy and TACE only respectively.The rate of objective response after 7 months was 84%and 44%in the RFA-TACE and TACE groups respectively.One year disease free survival rate was 56%and 24%in RFA-TACE and TACE groups respectively,and overall survival rate was 88%in the RFA-TACE group and 80%in the TACE only group.Conclusion:Combined RFA-TACE appears to be an effective modality and superior to TACE only for the treatment of HCC. | Ahmed Kamal El Dorry Eman Mahmoud Fathy Barakat Amal Tohamy Abd ElMoez Mervat Abd Fatah Mawad Nevien Fouad El-Fouly Mohamed Kamal Shaker | 2015 | Hepatoma Research2015，1，1： | 1 |
| 13 | Medicinal and biological values of Callistemon viminalis extracts:History,current situation and prospects显示文摘Callistemon viminalis(C.viminalis)is a plant that has been reported to have a various medicinal values such as antibacterial,antifungal,antioxidant activities and other pharmaceutical and insecticidal properties.This review covers the potentials,applications and properties of different extracts from different parts(branches,flowers,fruits,bark,leaves)of C.viminalis.Furthermore,the chemical structures of the bioactive compounds were reported for biological activities.All the results supported the traditional uses of C.viminalis in folk medicine.In addition,some researches supported the use of C.viminalis extracts for the preparation of metal oxide nanoparticles. | Mohamed Z.M.Salem Mervat EL-Hefny Ramadan A.Nasser Hayssam M.Ali Nader A.El-Shanhorey Hosam O.Elansary | 2017 | Asian Pacific Journal of Tropical Medicine2017，10，3： | 1 |
| 14 | Continuous production of oligosaccharides from whey using a membrane reactor显示文摘 | Mervat I F Lopez-Leiva M | 2000 | Process Biochemistry2000，35，： | 1 |
| 15 | Using Objective Structured Clinical Examination (OSCE) in Undergraduate Psychiatric Nursing Education: Is It Reliable and Valid?显示文摘 | Abeer A S Fatma H R Mervat M E | 2012 | Nurse Edue Today2012，32，3： | 1 |
| 16 | Vascular endothelial growth factor before and after locoregional treatment and its relation to treatment response in hepatocelluar carcinoma patients显示文摘Objective:To evaluate vascular endothelial growth factor(VEGF)levels in hepatocellular carcinoma patients before and after transcatheter arterial chemoembolization(TACE)and percutaneous ethanol injection(PEI)and its relation to treatment response.Methods:A total of 40 patients with unrespectable hepatocelluar carcinoma were assessed clinically.Twenty patients were suitable to be treated by TACE,while other 20patients were treated with PEI.Serum VEGF levels were measured before and 1 month after each procedure by ELISA.Response was assessed after 1 month according to Union Internationale Contre le Cancer evaluation criteria based on change in tumor size as measured by ultrasound.Results:There was no significant difference between TACE and PEI groups with regard to age,sex,tumor size,response to local therapy,or VEGF and alpha-fetoprotein before and after therapy.VEGF levels after TACE were significantly higher than before TACE[(298.1±123.6)pg/m L vs.(205.8±307.3)pg/m L;P=0.001].Also,VEGF levels were significantly higher after PEI than before PEI[(333.8±365.6)pg/m L vs.(245.3±301.8)pg/m L;P=0.000].Non-responders of both groups had significantly high VEGF levels than responder's,both before[(985.0±113.2)pg/m L vs.(117.1±75.3)pg/m L;P<0.001]and after therapy[(1 330.6±495.7)pg/m L vs.(171.0±94.7)pg/m L;P=0.000)].Conclusions:Both TACE and PEI were associated with an increase in serum VEGF in hepatocelluar carcinoma patients.Higher levels of VEGF before and after therapy were found in non-responders,suggesting that VEGF is a useful marker in predicting treatment response. | Heba Sedrak Noaman El-Garem Mervat Naguib Heba El-Zawahry Mohamed Esmat Lila Rashed | 2015 | Asian Pacific Journal of Tropical Biomedicine2015，5，12： | 1 |
| 17 | Data Management forthe Internet of Things:Design Primitives andSolution显示文摘 | Mervat Abu-Elkheir MohammadHayajneh Najah Abu Ali | 2013 | Sensors2013，，15： | 1 |
| 18 | Newroutes to steroidal heterocyclic derivatives:Synthesis of biologically active pyrazolyl- and isoxazolylpregnene de- rivatives显示文摘 | Abdelhamid A O Mervat M A Gamal A E | 2007 | J Heterocyclic Chem2007，44，1： | 1 |
| 19 | Assessment of Left Ventricular Mechanical Dyssynchrony Using Real Time Three‐Dimensional Echocardiography: A Comparative Study to Doppler Tissue Imaging显示文摘 | RaniaSamir MazenTawfik Ahmed M.El Missiri GhadaEl Shahid Mervat AboulMaaty MaiyEl Sayed | 2012 | Echocardiography2012，，2： | 1 |
| 20 | Brain aging in normal Egyptians: cognition, education, personality, genetic and immunological study显示文摘 | Osamah Elwan Obsis Madkour Fadia Elwan Mervat Mostafa Azza Abbas Helmy Maged Abdel-Naseer Sanaa Abdel Shafy Nervana El Faiuomy | 2003 | Journal of the Neurological Sciences2003，，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员